Pfizer dumps a hemophilia pact with Catalyst, threatening its Targacept merger - FierceBiotech

/

http://ift.tt/1aNAUOT Click to read full article...

Pfizer dumps a hemophilia pact with Catalyst, threatening its Targacept mergerFierceBiotechSix years after Catalyst Biosciences inked a $500 million-plus deal to develop a Factor VIIa therapies for hemophilia, Pfizer is walking away from the pact it inherited from Wyeth. And now Targacept, which just struck a reverse merger pact to get ...

from Hemophilia - Google News http://ift.tt/1aNAUOT via IFTTT

Research and Markets: Global Hemophilia Pipeline Highlights Report 2014-2015 - Digital Journal

/

http://ift.tt/1cbB1nG Click to read full article...

Research and Markets: Global Hemophilia Pipeline Highlights Report 2014-2015Digital JournalThe latest report Hemophilia Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Hemophilia market. It covers emerging therapies for Hemophilia in active clinical development stages including early ...and more »

from Hemophilia - Google News http://ift.tt/1cbB1nG via IFTTT

Research and Markets: Global Hemophilia Pipeline Highlights Report 2014-2015 - Business Wire (press release)

/

http://ift.tt/1a6P4cH Click to read full article...

Research and Markets: Global Hemophilia Pipeline Highlights Report 2014-2015Business Wire (press release)The latest report Hemophilia Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Hemophilia market. It covers emerging therapies for Hemophilia in active clinical development stages including early ...and more »

from Hemophilia - Google News http://ift.tt/1a6P4cH via IFTTT

Philippine hemophilia community seeks public support - InterAksyon

/

http://ift.tt/1adZzev Click to read full article...

InterAksyon

Philippine hemophilia community seeks public supportInterAksyonMANILA - In celebration of World Hemophilia Day on April 17, the Hemophilia Association of the Philippines for Love & Service (HAPLOS) will spearhead a national gathering of different hemophilia groups and support organizations at the Glorietta Mall in ...

from Hemophilia - Google News http://ift.tt/1adZzev via IFTTT

Hemophilia in the Managed Care Setting - AJMC.com Managed Markets Network

/

http://ift.tt/1DUVnfN Click to read full article...

Hemophilia in the Managed Care SettingAJMC.com Managed Markets NetworkHemophilia A and B are chronic inherited bleeding disorders that together rank as one of the most expensive chronic diseases in the United States. Factor replacement products, which are the mainstay of treatment, are among the most expensive therapies, ...

from Hemophilia - Google News http://ift.tt/1DUVnfN via IFTTT

Catalyst Bio regains ownership of hemophilia product candidate - Seeking Alpha

/

http://ift.tt/1yP8adJ Click to read full article...

Catalyst Bio regains ownership of hemophilia product candidateSeeking AlphaFollowing to its previously announced merger with Targacept (TRGT -10.9%), Catalyst Biosciences discloses that Pfizer (PFE +0.1%) has terminated its 2009 license agreement with Catalyst for its lead product candidate, CB 813d, for the treatment of ...Targacept (TRGT) Announces Termination of Catalyst/Wyeth Research ...StreetInsider.comall 3 news articles »

from Hemophilia - Google News http://ift.tt/1yP8adJ via IFTTT

RVCC to host Hemophilia Awareness Walk, May 3 - NJ.com

/

http://ift.tt/19TBCZC Click to read full article...

RVCC to host Hemophilia Awareness Walk, May 3NJ.comRaritan Valley Community College's Student Nurses Association and students in the College's Trends in Nursing class are partnering with the Hemophilia Association of New Jersey for the fourth annual Hemophilia Bleeding Disorders Awareness Walk, ...

from Hemophilia - Google News http://ift.tt/19TBCZC via IFTTT

Hemophilia B Global Clinical Trials Review H2 2014 - PharmiWeb.com (press release)

/

http://ift.tt/1DtoOXJ Click to read full article...

Hemophilia B Global Clinical Trials Review H2 2014PharmiWeb.com (press release)GlobalData's clinical trial report "Hemophilia B Global Clinical Trials Review H2 2014" provides data on the Hemophilia B clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemophilia B. It ...

from Hemophilia - Google News http://ift.tt/1DtoOXJ via IFTTT

Hemophilia in the Managed Care Setting - AJMC.com Managed Markets Network

/

http://ift.tt/1GeuEuT Click to read full article...

Hemophilia in the Managed Care SettingAJMC.com Managed Markets NetworkHemophilia A and B are chronic inherited bleeding disorders that together rank as one of the most expensive chronic diseases in the United States. Factor replacement products, which are the mainstay of treatment, are among the most expensive therapies, ...

from Hemophilia - Google News http://ift.tt/1GeuEuT via IFTTT

rIX-FP Regulatory Submissions Now Made in EU and US; Underscores CSL ... - Virtual Press Office (press release)

/

http://ift.tt/1GaVyno Click to read full article...

rIX-FP Regulatory Submissions Now Made in EU and US; Underscores CSL ...Virtual Press Office (press release)"The EMA beginning its Centralized Procedure for rIX-FP is a significant milestone for CSL Behring's recombinant factor IX clinical development program and moves us one step closer to bringing this innovative therapy to hemophilia B patients in the EU ...and more »

from Hemophilia - Google News http://ift.tt/1GaVyno via IFTTT

Novo to Launch Novoeight in the U.S. for People With Hemophilia A - Drug Discovery & Development

/

http://ift.tt/19ByscF Click to read full article...

Drug Discovery & Development

Novo to Launch Novoeight in the U.S. for People With Hemophilia ADrug Discovery & DevelopmentNovo Nordisk announced the company will launch Novoeight (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A. Novoeight offers purity, reliability, and enhanced portability, with the highest storage ...Annualized Bleeding Rates Reduced Using Treatment with Turoctocog AlfaHCPLiveall 4 news articles »

from Hemophilia - Google News http://ift.tt/19ByscF via IFTTT

Streamlining and Improving Hemophilia Treatment and Care - HCPLive

/

http://ift.tt/1ab9G4C Click to read full article...

HCPLive

Streamlining and Improving Hemophilia Treatment and CareHCPLiveResearchers from the National Blood Centre in Rome, Italy invited a panel of experts to discuss recommendations to monitor indicators of hemophilia in order to reduce the social health burden of inherited bleeding disorders like hemophilia and its ...and more »

from Hemophilia - Google News http://ift.tt/1ab9G4C via IFTTT

Analysis of Current Challenges Facing Hemophilia Patients and Physicians - HCPLive

/

http://ift.tt/1Detmj9 Click to read full article...

HCPLive

Analysis of Current Challenges Facing Hemophilia Patients and PhysiciansHCPLiveHemophilia patients generally have highly effective and safe treatments despite challenges in medication administration, according to findings published in the quarterly journal Blood Transfusion. Researchers from the Regional Reference Centre for ...

from Hemophilia - Google News http://ift.tt/1Detmj9 via IFTTT

Hemophilia B Gene Therapy Trial Effective and Saves Money - HCPLive

/

http://ift.tt/1Nz77Hu Click to read full article...

HCPLive

Hemophilia B Gene Therapy Trial Effective and Saves MoneyHCPLiveResearchers from St. Jude Children's Hospital, University College London, and the Royal Free Hospital treated 10 male hemophilia B patients with 3 doses of AAV8 in order to determine the durability of transgene expression, the relationship between ...

from Hemophilia - Google News http://ift.tt/1Nz77Hu via IFTTT

Participating Faculty: Hemophilia: Managing the Cost of Care With a Focus on ... - AJMC.com Managed Markets Network

/

http://ift.tt/1OOCgrW Click to read full article...

Participating Faculty: Hemophilia: Managing the Cost of Care With a Focus on ...AJMC.com Managed Markets NetworkThis supplement to The American Journal of Managed Care will provide an epidemiological and clinical overview of hemophilia, discuss current and emerging pharmacotherapeutic strategies, evaluate the burden of disease, and discuss the importance of ...

from Hemophilia - Google News http://ift.tt/1OOCgrW via IFTTT

Novo Nordisk to Launch Novoeight in the U.S. for People With Hemophilia A - Drug Discovery & Development

/

http://ift.tt/19kuZQ4 Click to read full article...

Drug Discovery & Development

Novo Nordisk to Launch Novoeight in the U.S. for People With Hemophilia ADrug Discovery & DevelopmentNovo Nordisk announced the company will launch Novoeight (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A. Novoeight offers purity, reliability, and enhanced portability, with the highest storage ...

from Hemophilia - Google News http://ift.tt/19kuZQ4 via IFTTT

East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More - Xconomy

/

http://ift.tt/1FRtSWd Click to read full article...

East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & MoreXconomyFor those looking to get away from the broader biotech indices' plummet this week (the Nasdaq Biotechnology Index (NASDAQ: IBB) fell 7 percent), we've got your comfort food here: a feature about gene therapy's long quest to cure hemophilia, a ...

from Hemophilia - Google News http://ift.tt/1FRtSWd via IFTTT

Novo Nordisk announces U.S. launch of Novoeight for people living with ... - News-Medical.net

/

http://ift.tt/1IzHGmo Click to read full article...

Novo Nordisk announces U.S. launch of Novoeight for people living with ...News-Medical.netNovo Nordisk today announced the company will launch Novoeight® (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A. Novoeight® offers purity, reliability, and enhanced portability, with the highest storage ...Novo Nordisk to Launch Novoeight® in the United States for People With ...PR Newswire (press release)all 3 news articles »

from Hemophilia - Google News http://ift.tt/1IzHGmo via IFTTT

Novo Nordisk to Launch Novoeight® in the United States for People With ... - SYS-CON Media (press release)

/

http://ift.tt/1BtU8za Click to read full article...

Novo Nordisk to Launch Novoeight® in the United States for People With ...SYS-CON Media (press release)PLAINSBORO, N.J., March 26, 2015 /PRNewswire/ -- Novo Nordisk today announced the company will launch Novoeight® (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A. Novoeight® offers purity, reliability, and ...and more »

from Hemophilia - Google News http://ift.tt/1BtU8za via IFTTT

Novo Nordisk to Launch Novoeight® in the United States for People With ... - PR Newswire (press release)

/

http://ift.tt/1E5t1Ax Click to read full article...

Novo Nordisk to Launch Novoeight® in the United States for People With ...PR Newswire (press release)PLAINSBORO, N.J., March 26, 2015 /PRNewswire/ -- Novo Nordisk today announced the company will launch Novoeight® (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A. Novoeight® offers purity, reliability, and ...and more »

from Hemophilia - Google News http://ift.tt/1E5t1Ax via IFTTT